Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shaanxi Boyitong Pharmaceutical Technology is a China-based enterprise dedicated to the research, development, and production of pharmaceutical intermediates and fine chemicals. Headquartered in Xi'an, the company operates as a Contract Research Organization (CRO) providing custom synthesis, process development, and technical consulting services to the global pharmaceutical industry. Their product catalog features a diverse range of chemical building blocks and intermediates essential for the synthesis of active pharmaceutical ingredients (APIs). The company's technical expertise supports various therapeutic areas, including oncology, infectious diseases, and cardiovascular health. Shaanxi Boyitong emphasizes quality control and innovation to meet the rigorous standards of international drug development partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shaanxi Boyitong Pharmaceutical Technology.